Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Shin Poong Pharmaceutical Co., Ltd. Preferred Stock (019175:KRX), powered by AI.
Shin Poong Pharmaceutical Co., Ltd. Preferred Stock is currently trading at ₩14,110. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Shin Poong Pharmaceutical Co., Ltd. Preferred Stock on Alpha Lenz.
Shin Poong Pharmaceutical Co., Ltd. Preferred Stock's P/E ratio is 82.0.
“Shin Poong Pharmaceutical Co., Ltd. Preferred Stock trades at a P/E of 82.0 (premium valuation) with modest ROE of 3.4%.”
Ask for details →Shin Poong Pharmaceutical Co., Ltd. Preferred Stock is a type of equity security that represents a financial claim on the company distinct from its common stock. These shares are designed to provide shareholders with preferential treatment in dividend distributions and, potentially, in bankruptcy proceedings, depending on the company's policies. Shin Poong Pharmaceutical, a key player in the pharmaceutical industry, focuses on developing, manufacturing, and distributing a wide range of medical products, including medications, vaccines, and active pharmaceutical ingredients. This preferred stock offers a stable dividend income, which can be particularly appealing to investors seeking consistent returns without necessarily benefiting from voting rights associated with common stock. Predominantly impacting healthcare and pharmaceutical sectors, Shin Poong's market role is crucial, given its commitment to innovative drug development and expanding global healthcare access. The preferred stock serves as a crucial financial instrument, facilitating the company’s capital-raising efforts while ensuring shareholders receive a return on investment during profitable periods.
“Shin Poong Pharmaceutical Co., Ltd. Preferred Stock trades at a P/E of 82.0 (premium valuation) with modest ROE of 3.4%.”
Ask for details →Shin Poong Pharmaceutical Co., Ltd. Preferred Stock (ticker: 019175) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 809 employees. Market cap is $28.1B.
The current price is ₩14,110 with a P/E ratio of 82.03x and P/B of 2.68x.
ROE is 3.35% and operating margin is 6.07%. Annual revenue is $234.7B.